Access Pharmaceuticals (ACCP.OB) Continues Advancements with Cobalamin-Mediated Targeted Drug Delivery Platform for siRNA

Filed in silver by on October 9, 2010 0 Comments

Proof-of-Principle Data for Proprietary CobaCyteTM Platform in siRNA ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary

Read more:
Access Pharmaceuticals (ACCP.OB) Continues Advancements with Cobalamin-Mediated Targeted Drug Delivery Platform for siRNA

Tags: , , , , , , , ,

About the Author ()

Leave a Reply

Your email address will not be published. Required fields are marked *